8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2025 / 2x2 factorial, double-blind, placebo-controlled randomized clinical trial
In the COSMOS trial, 8,905 older adults free of baseline hypertension were randomized to daily cocoa extract (500 mg/d cocoa flavanols with 80 mg/d [-]-epicatechin) or placebo. Over a median follow-up of 3.4 years, cocoa extract did not significantly reduce incident hypertension overall (7.1 vs 7.4 per 100 person-years; HR 0.96 [95% CI, 0.88-1.05]). However, in subgroup analysis, cocoa extract reduced incident hypertension among participants with baseline systolic BP <120 mm Hg (HR 0.76 [95% CI, 0.64-0.90]), but not among those with baseline systolic BP of 120 to 139 mm Hg (HR 1.05 [95% CI, 0.93-1.18]; P-interaction=0.002).
Hamaya R, Li S, Lau J, et al. Hypertension, 2025. PMID 40832703
2022 / Randomized, triple-blind, placebo-controlled, cross-over clinical trial
In a triple-blind, placebo-controlled crossover trial, 51 hypertensive patients received either celery seed capsules (1.34 g extract daily) or placebo for 4 weeks alongside usual medications. Celery seed extract was safe, reduced blood pressure, and decreased FBS from 108.53 to 97.96 mg/dL (p < 0.01). Significant reductions were seen in BUN (3.43 mg/dL), SCr (0.075 mg/dL), SGPT (4.08 U/L), SGOT (3.03 U/L), TC (16.37 mg/dL), TG (16.22 mg/dL), and LDL (11.84 mg/dL), along with an increase in HDL of 2.52 mg/dL (all p < 0.05 or p < 0.001). No significant changes were found in blood cells or serum electrolytes; the study was limited by a small sample size.
Shayani Rad M, Moohebati M, MohammadEbrahimi S, et al. Inflammopharmacology, 2022. PMID 35536382
2022 / Randomized, triple-blind, placebo-controlled, cross-over clinical trial
A randomized, triple-blind, placebo-controlled crossover trial evaluated the effect of 4 celery seed extract capsules (1.34 g/day) versus placebo taken daily for 4 weeks in 52 hypertensive patients. In the celery group, systolic blood pressure decreased from 141.2 ± 5.91 to 130.0 ± 4.38 mmHg (p < .001) and diastolic blood pressure decreased from 92.2 ± 5.74 to 84.2 ± 4.87 mmHg (p < .001). Mean arterial blood pressure also changed from 108.5 ± 5.76 to 99.5 ± 4.66 mmHg (p < .001), and pulse pressure decreased from 49.0 ± 6.21 to 45.8 ± 6.01 mmHg (p < .01), whereas no significant changes occurred with placebo (p > .05). No significant side effects were reported in the celery group compared to placebo (p > .05).
Shayani Rad M, Moohebati M, Mohajeri SA Phytother Res, 2022. PMID 35624525
2022 / Uncontrolled interventional program evaluation
Participants enrolled in a 15-day Jumpstart program were instructed to consume an Esselstyn-compliant, whole-food plant-based diet of vegetables, fruits, whole grains, and legumes. Among 389 participants, average weight loss was 5.8 pounds (7.3 for BMI >30), systolic blood pressure dropped by 6.8 points (16.8 for baseline >140), cholesterol decreased by 26 points (44 for baseline >200), LDL dropped by 19 points (33 for baseline >100), and fasting blood sugar fell by 5.1 points (28.4 for those starting in the diabetic range). All reported comparisons achieved statistical significance (P < .005 for fasting blood sugar and P < .001 for all others).
Friedman SM, Barnett CH, Franki R, et al. Am J Lifestyle Med, 2022. PMID 35706593
2021 / Randomized, double-blind, phase 3a withdrawal trial
Following a 20-week run-in with subcutaneous semaglutide resulting in a mean weight loss of 10.6%, 803 participants were randomized to 48 weeks of continued semaglutide (2.4 mg/week) or placebo, both with lifestyle intervention. From week 20 to 68, participants continuing semaglutide had a mean weight change of -7.9% compared to +6.9% with placebo (difference: -14.8 percentage points, P < .001). Continued semaglutide also led to greater improvements in waist circumference (-9.7 cm), systolic blood pressure (-3.9 mm Hg), and physical functioning scores. Gastrointestinal adverse events were reported in 49.1% of semaglutide participants versus 26.1% with placebo, though discontinuation rates due to adverse events were similar (2.4% vs 2.2%).
Rubino D, Abrahamsson N, Davies M, et al. JAMA, 2021. PMID 33755728
2020 / Single-blinded randomized pilot study
Forty participants with type 2 diabetes mellitus were randomized to 3 months of either yoga (postures and breathing exercises, n = 20) or sham yoga (nonaerobic stretching, n = 20). Both groups demonstrated significant within-group improvements in malondialdehyde, vitamin C, superoxide dismutase, fasting blood glucose, glycosylated hemoglobin, body mass index, waist circumference, and blood pressure. Yoga participants showed significantly greater improvement in reduced glutathione compared to controls, but no other significant differences between groups were observed.
Hegde SV, Adhikari P, Kotian SM, et al. Int J Yoga Therap, 2020. PMID 31283365
2020 / Randomized controlled trial
In a randomized controlled trial, 143 subjects with essential prehypertension and high-normal serum uric acid (SUA) levels were assigned to receive 2 × 100 g soursop fruit juice daily or no treatment for 3 months. The soursop group showed significantly lower mean systolic blood pressure after adjustment across examinations, and the control group was more likely to have prehypertension, hypertension, and high-normal or high SUA levels at 6 and 12 weeks. In an analysis using 2017 ACC/AHA guidelines, both systolic and diastolic blood pressure were significantly lower in the treatment group than the control group after 12 weeks.
Alatas H, Sja'bani M, Mustofa M, et al. J Hum Hypertens, 2020. PMID 31462727
2020 / Cluster randomized trial
The Salt Substitute and Stroke Study is an ongoing 5-year cluster randomized trial evaluating potassium-enriched salt substitute versus usual salt in 20,996 individuals across 600 Chinese villages. Intermediate markers assessed over 3 years showed mean differences between the intervention and control groups of -0.32 g (95% CI: -0.68 to 0.05) for 24-hour urinary sodium, +0.77 g (+0.60 to +0.93) for 24-hour urinary potassium, and -2.65 mmHg (-4.32 to -0.97) for systolic blood pressure. Diastolic blood pressure difference was +0.30 mmHg (-0.72 to +1.32). Salt substitute use was 97.5% in the intervention group versus 4.2% in controls, and the overall annual fatal and non-fatal stroke rate across the first 2 years was 3.2%.
Huang L, Tian M, Yu J, et al. Am Heart J, 2020. PMID 31986290
2020 / Cluster randomized trial
A cluster randomized trial in 2,376 participants in Peru evaluated replacing household salt with a 75% sodium chloride and 25% potassium chloride substitute. The intervention reduced systolic blood pressure by 1.29 mm Hg (95% CI -2.17 to -0.41) and diastolic blood pressure by 0.76 mm Hg (95% CI -1.39 to -0.13). Among participants normotensive at baseline, salt substitution was linked to a 51% lower risk of developing hypertension (95% CI 29% to 66%).
Bernabe-Ortiz A, Sal Y Rosas VG, Ponce-Lucero V, et al. Nat Med, 2020. PMID 32066973
2020 / Parallel-group, double-blind, randomized controlled trial
A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.
Witham MD, Lees JS, White M, et al. J Am Soc Nephrol, 2020. PMID 32817311
2020 / Randomized controlled trial
Ninety-nine mildly hypertensive participants aged 40-65 years completed a 4-week low-polyphenol diet (LPD) washout and were then randomized to either an LPD or a high-polyphenol diet (HPD) for 8 weeks. Participants in the HPD group reported a decrease in depressive symptoms on the Beck Depression Inventory-II, alongside improved physical and mental health component scores on the 36-Item Short Form Survey. No differences were observed for anxiety, stress, self-esteem, or body image perception.
Kontogianni MD, Vijayakumar A, Rooney C, et al. Nutrients, 2020. PMID 32823886
2019 / Interventional study
Researchers used 16S rRNA gene sequencing to assess the effects of 1 week of chlorhexidine antiseptic mouthwash on tongue bacterial communities and resting systolic blood pressure in healthy, normotensive individuals free of oral disease. Tongue cleaning frequency predicted chlorhexidine-induced changes in blood pressure and microbiome composition. Twice-daily chlorhexidine use was associated with a significant increase in systolic blood pressure after 1 week, and recovery led to enrichment of nitrate-reducing bacteria. Furthermore, participants with relatively high levels of bacterial nitrite reductases demonstrated lower resting systolic blood pressure.
Tribble GD, Angelov N, Weltman R, et al. Front Cell Infect Microbiol, 2019. PMID 30881924
2019 / Cluster randomized controlled trial
A cluster randomized trial evaluated an 8-module workplace wellness program led by dietitians across 160 worksites (20 intervention sites with 4,037 employees and 140 control sites with 28,937 employees). After 18 months, intervention participants reported higher rates of engaging in regular exercise (69.8% vs 61.9%; adjusted difference, 8.3 percentage points) and actively managing weight (69.2% vs 54.7%; adjusted difference, 13.6 percentage points). However, there were no significant effects on 27 other self-reported outcomes (including food choices), 10 clinical markers (including cholesterol, blood pressure, and BMI), 38 health spending/utilization metrics, or 3 employment outcomes.
Song Z, Baicker K JAMA, 2019. PMID 30990549
2019 / Randomized, parallel, controlled trial
Sixty-six patients with NAFLD were randomly assigned to a 500-calorie deficit diet either with or without 240 ml/day of soy milk for 8 weeks. Compared to the control group, the soy milk group showed significantly greater reductions in serum insulin (-3.44 ± 5.02 vs. -1.09 ± 3.77 μIU/ml, P = 0.04), HOMA-IR (-0.45 ± 0.64 vs -0.14 ± 0.47, P = 0.03), systolic BP (-3.81 ± 4.15 vs -1.48 ± 2.93 mmHg, P = 0.01), and diastolic BP (-2.39 ± 2.80 vs. -0.94 ± 2.76 mmHg, P = 0.04), plus a significant increase in QUICKI (0.02 ± 0.032 vs. 0.008 ± 0.018, P = 0.04). Changes in fasting blood sugar, HOMA-β%, fibrinogen, and malondialdehyde did not differ significantly between groups.
Maleki Z, Jazayeri S, Eslami O, et al. Complement Ther Med, 2019. PMID 31126574
2019 / Single-arm pre-post intervention study
Researchers evaluated an 8-week group program utilizing an ad-libitum whole-food plant-based dietary pattern in 79 self-referred participants, with 78 completing. Completers achieved an average weight loss of 5.5 ± 3.0 kg (p < 0.0001), with larger percentage losses in those with higher baseline BMI. Systolic blood pressure decreased by 7.1 ± 15.5 mmHg (p = 0.0002), diastolic blood pressure decreased by 7.3 ± 10.9 mmHg (p < 0.0001), total cholesterol decreased by 25.2 ± 24.7 mg/dL (p < 0.0001), and LDL decreased by 15.3 ± 21.1 mg/dL (p < 0.0001). Additionally, 21 participants (26.9%) decreased or stopped at least one chronic medication.
Campbell EK, Fidahusain M, Campbell Ii TM Nutrients, 2019. PMID 31484341
1997 / Narrative review
This review summarizes the health-protective benefits of phytochemicals found in plant-rich diets. Nuts, whole grains, fruits, and vegetables provide phenolic compounds, terpenoids, pigments, and natural antioxidants linked to the prevention or treatment of heart disease, cancer, diabetes, and hypertension. Garlic, soybeans, cabbage, ginger, licorice, and umbelliferous vegetables are identified among foods with the highest anticancer activity, while citrus and grains supply active compounds reducing risks of cardiovascular disease and cancer.
Craig WJ J Am Diet Assoc, 1997. PMID 9336591
1997 / Narrative review
Despite substantial declines in mean blood lead levels in the United States, certain population segments still have elevated blood lead concentrations, and residents of industrialized countries carry high bone lead stores. Studies indicate these skeletal lead stores contribute to reduced birth weights, aggressive behavior in children, and anemia, hypertension, and kidney disease in adults. The review describes evidence demonstrating that increased dietary calcium consumption can reduce lead absorption and toxicity from exogenous and endogenous lead sources.
Bogden JD, Oleske JM, Louria DB Environ Health Perspect, 1997. PMID 9405321
1995 / Narrative review
This review discusses the relationship between hypercortisolism, stress axis activation, and obesity. Visceral fat is most strongly associated with morbidity and mortality from cardiocerebrovascular disease and diabetes, as well as metabolic syndrome (hypertension, hyperlipidemia, hyperinsulinemia, and insulin resistance). Metabolic syndrome is also present in Cushing's syndrome, characterized by primary hypercortisolism and profound visceral adiposity. Chronic physical or psychological stress impacts body composition through glucocorticoids, significantly affecting survival.
Shows an association, not proof of cause and effect.
Peeke PM, Chrousos GP Ann N Y Acad Sci, 1995. PMID 8597440
1993 / Regulatory hazard assessment review
This regulatory assessment evaluated lead exposure and its adverse effects across different populations. Blood lead levels as low as 10 micrograms/dl were associated with impaired neurobehavioural and cognitive development, electrophysiological deficits in children, and reduced gestational age and birth weight in infants. In adults, blood lead levels of 30 micrograms Pb/dl were linked to elevated blood pressure and other adverse effects. Ingestion levels producing these concern levels were estimated at 60 micrograms/day for children <=6 years, 150 micrograms/day for children >=7 years, 250 micrograms/day for pregnant women, and 750 micrograms/day for adults.
Shows an association, not proof of cause and effect.
Carrington CD, Sheehan DM, Bolger PM Food Addit Contam, 1993. PMID 8359314
1993 / Literature review
A review of case reports, clinical studies, and biochemical data evaluated the health hazards of glycyrrhizic acid in liquorice sweets. High intake causes hypermineralocorticoidism via 11 beta-hydroxysteroid dehydrogenase inhibition, leading to sodium retention, potassium loss, oedema, hypertension, and renin-angiotensin-aldosterone suppression. In sensitive individuals, a regular daily intake of ~100 mg glycyrrhizic acid (~50 g liquorice sweets at 0.2% content) can cause adverse effects, and most experience adverse effects at 400 mg daily. Using 100 mg/day as the lowest-observed-adverse-effect level and a safety factor of 10, a daily intake of 10 mg represents a safe dose for most healthy adults.
Størmer FC, Reistad R, Alexander J Food Chem Toxicol, 1993. PMID 8386690
1992 / Critical review of clinical trials
A review critically appraised 22 recent articles of trials evaluating physical activity as a means of reducing blood pressure. Overall, blood pressure was reduced by physical activity in both hypertensive and normotensive persons, an effect that was independent of weight loss. In the better designed studies, average reductions were approximately 6-7 mmHg for both systolic and diastolic blood pressure, which was smaller than reductions reported in poorer designed studies. All activities lowered blood pressure, and daily activity produced greater reductions than activity performed three times per week. The quality of the literature remained poor, and of the 13 controlled trials of habitual activity, only one did not have a major design fault.
Arroll B, Beaglehole R J Clin Epidemiol, 1992. PMID 1588350
1989 / Narrative review
This review examined evidence on whether reducing body weight and sodium intake can lower blood pressure and prevent hypertension. Evidence from cross-sectional, longitudinal, and intervention studies suggests hypertension can be prevented by avoiding excessive weight, especially in children and adolescents to prevent adult hypertension. In contrast, the hypothesis that sodium restriction reduces hypertension was viewed as less convincing, and the degree of restriction needed may make it less practical than weight loss.
Staessen J, Fagard R, Lijnen P, et al. J Hypertens Suppl, 1989. PMID 2651610
1989 / Narrative review
This review examines evidence on the role of upper-body obesity in mediating cardiovascular risk factors through hyperinsulinemia. Upper-body predominance of weight connects hypertension, diabetes, and hypertriglyceridemia, even without significant overall obesity. The author notes that caloric excess in the presence of androgens typically induces upper-body obesity, highlighting the need to prevent it or provide treatments that do not exacerbate hyperinsulinemia.
Kaplan NM Arch Intern Med, 1989. PMID 2662932
1976 / Narrative review
This review evaluates four primary lines of evidence supporting the prevention of hypertension through salt restriction: epidemiological studies in unacculturated groups linking lower salt intake to hypertension prevalence, hemodynamic findings relating chronic experimental hypertension to increased extracellular fluid volume (ECF), differences in ECF between salt eaters and non-salt eaters, and clinical investigations showing blood pressure falls with ECF reduction via salt restriction or diuretics. The author concludes that reducing dietary salt to below 2 g/day would result in the prevention of essential hypertension, although the precise mechanism remains obscure.
Freis ED Circulation, 1976. PMID 767020